14, Oct 2025
Hamdard Honey: The Golden Standard of Assured Quality
Delhi, 14 October, 2025: For over a century, Hamdard Foods India has stood for purity, trust, and wellness. At the heart of its portfolio is Hamdard Honey, a product that has become a symbol of natural goodness and health. Carefully sourced from the finest apiaries and processed, Hamdard Honey is packed with the assurance of Quality & Food Safety Standard. making it an everyday refined sugar replacer that fits seamlessly into today’s fast-paced lifestyles.
A natural replacement for refined sugar, Hamdard Honey is more than just a sweetener it’s a home essential. Whether drizzled over breakfast, stirred into teas, blended into smoothies, or simply consumed with warm water, Hamdard Honey offers a great way to start the day. Backed by stringent quality checks, it ensures every drop has assured quality and trust, true to Hamdard’s uncompromising legacy.
Speaking about the brand’s focus, Mr. Hamid Ahmed, CEO of Hamdard Foods India, said: “Hamdard Honey represents everything we stand for quality, trust, and safety standards. Consumers today are looking for natural alternatives to ultra processed foods, and Hamdard Honey delivers exactly that. It’s not just about taste, it’s about life with the goodness of nature. At Hamdard, we remain committed to bringing products that inspire smart choices without compromise.”
With the association of Aditi Rao Hydari with Hamdard Honey, she strengthens the brand’s legacy and promise with her natural elegance and genuine lifestyle. Aditi embodies the “No Compromise” philosophy, reflecting how purity and quality are non-negotiable when it comes to health and well-being.
Sharing her thoughts, Aditi Rao Hydari said: “For me, wellness is all about simple, pure choices and Hamdard Honey represents that perfectly. It’s versatile, natural, and something I can trust completely. Whether I use it in my morning routine or in recipes, Hamdard Honey assures me that I’m making the right choice for my health.”
With its blend of trust and innovation, Hamdard Honey continues to inspire families to adopt wiser lifestyles. As the best form of nature’s sweetness, it remains a trusted ally for taste, and well-being ensuring that when it comes to honey, there is simply no compromise in terms of Quality & Food Safety Standards.
- 0
- By Neel Achary
14, Oct 2025
Wholesale Price Inflation Eases to 0.13% in September 2025 as Food and Energy Prices Moderate: PHDCCI
Wholesale Price Index (WPI) data for September 2025 (Provisional), showing that the annual inflation rate stood at 0.13 percent compared to September 2024. On a month-on-month basis, the WPI declined by 0.19 percent, reflecting continued moderation in wholesale price pressures, said Mr. Rajeev Juneja, President, PHDCCI in a press statement issued here today.
The low overall inflation in September was primarily driven by declines in food and primary article prices, even as manufactured product prices showed a mild increase. In the Primary Articles category, prices fell largely due to lower prices of cereals, pulses, vegetables, and non-food articles such as fibres and oilseeds, which is also reflected in CPI for September 2025, he said.
He added the moderation in wholesale prices was mainly due to lower food and energy costs, a strong agricultural output, and stable commodity prices globally. Improved supply-side conditions following a good monsoon, alongside government interventions to check retail prices of essential commodities, also contributed to the decline.
However, the manufactured goods sector continued to witness moderate price rises due to elevated input costs, particularly for raw materials like metals and chemicals, and steady domestic demand in industrial sectors such as cement, steel, and consumer durables, he said.
International crude oil prices showed mild volatility during the month, but remained range-bound, preventing a significant pass-through to domestic fuel inflation. Meanwhile, favourable currency movements and easing global commodity prices (particularly in edible oils and industrial inputs) further reduced cost pressures on producers, he said.
Looking ahead, wholesale inflation is expected to remain benign in the coming months, supported by adequate food supply, stable global commodity prices, and government measures to control inflation in key sectors. The harvest of kharif crops and the expected arrival of rabi produce in the next quarter are likely to keep food inflation contained, says Dr. Ranjeet Mehta, CEO & Secretary General, PHDCCI.
14, Oct 2025
JIS Group Chooses D2L Brightspace to Transform Learning Across Campuses
JIS Group Selects D2L Brightspace to Help Power the Future of Learning Across All Their Campus Institutions
Kolkata, India, October 14, 2025 : D2L, a global leader in learning technology, announced that the JIS Group, one of Eastern India’s largest and respected educational conglomerates has chosen D2L Brightspace as its new learning platform. This strategic move is a key milestone in JIS Group’s goal to fully digitize its campuses, enhance academic delivery, and elevate the learning experience for both students and faculty.
JIS Group has 45,000+ learners across campuses and is currently implementing D2L Brightspace Core with D2L Creator+ across all its institutions. D2L Brightspace will benefit students by helping to provide them with a unique experience through a blended learning approach. D2L Brightspace will also support faculty by helping to enable more dynamic, highly interactive teaching methods.
“D2L Brightspace expands the possibilities beyond simple course delivery, allowing our faculty to work more efficiently, create better learning experiences, enhance learning engagement, improve decision-making capabilities through real-time analytics, and ensure that every student has long-term access to their academic journey,” said Sardar Simarpreet Singh, Director – JIS Group. “With D2L Brightspace’s intuitive design and robust data capabilities, we can now foster a truly connected, collaborative environment where students continue to learn and grow well beyond the classroom.”
“This marks a significant milestone for D2L in India, strengthening our vision to redefine how learning is delivered and experienced across the country,” said Vivek Iyer, Managing Director for D2L India. “With D2L Brightspace, faculty and students will have access to a versatile, data-driven, and innovative platform that can help empower them to adapt and thrive in an education landscape that is evolving faster than ever before.”
D2L’s work with JIS Group reflects their effort to help digitize their campuses and lead with innovation, accessibility, and data-driven education. With its industry-recognized capabilities and robust support for blended and personalized learning, D2L Brightspace can offer a strategic, long-term solution to help empower JIS Group in delivering exceptional learning experiences and measurable outcomes.
14, Oct 2025
Bristol Myers Squibb Launches Kopozgo for oHCM Treatment in India
Bristol Myers Squibb Launches Kopozgo® (Mavacamten) in India for the treatment of symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM)
Hyderabad, India, October 14, 2025: Bristol Myers Squibb (BMS) today announced the launch of Kopozgo® (Mavacamten) in India. Kopozgo is the first and only oral, selective cardiac myosin inhibitor approved in India for the treatment of adults with symptomatic New York Heart Association (NYHA) Class II–III obstructive hypertrophic cardiomyopathy (oHCM).
Symptomatic obstructive HCM is an often-inherited heart disease that can be a chronic, debilitating and progressive condition where patients may experience symptoms of shortness of breath, dizziness and fatigue as well as serious, life-altering complications, including heart failure, arrhythmias, stroke and in rare cases (~1%) sudden cardiac death. It affects about 1 in 500 people worldwide, and it is estimated that as many as 2.8 million people in India may be living with the condition; however, 80-90 % patients remain undiagnosed.
Existing medical treatments in India, such as beta blockers, calcium channel blockers, and disopyramide, reduce symptoms but do not address the underlying cause. Invasive surgical procedures, including septal reduction therapy (alcohol septal ablation or myectomy), are options but may not be suitable or available for all patients. Additionally, these procedures require substantial operator and surgical expertise. Therefore, medical management of oHCM remains a major unmet need.
Kopozgo is the firstin-class disease-specific treatment targeting the core pathophysiological mechanism of obstructive HCM, leading to improvement in functional capacity of heart and symptoms.
Mavacamten was approved by the Central Drugs Standard Control Organisation (CDSCO) with an import license issued on March 6, 2025. Kopozgo is now available to patients in India. The approval of Kopozgo in India is based on positive efficacy and safety results from two Phase III clinical trials, EXPLORER-HCM and VALOR-HCM.
Sanjay Sharma, General Manager and Managing Director, BMS India, mentioned, “With the launch of Kopozgo in India, patients with oHCM now have a promising first-in-class treatment option. This breakthrough brings hope to individuals and families facing this condition, giving clinicians a novel therapy to address the unmet need in treatment. Bristol Myers Squibb is committed to advancing cardiovascular care for patients in India.”
Globally, mavacamten has been widely recognized, with its first approval granted by the U.S. Food and Drug Administration (FDA) on April 28, 2022, followed by approval from the European Union on June 26, 2023. Since then, the medicine has continued to expand its reach, receiving marketing authorization in more than 50 countries, underscoring its global significance as a breakthrough therapy for symptomatic obstructive hypertrophic cardiomyopathy.
In two phase III clinical studies, mavacamten has shown a consistent efficacy and safety profile. Some of the patients experienced a transient drop in ejection fraction (the heart’s pumping ability); however, all patients recovered following interruption.
Bristol Myers Squibb has been present in India for over 20 years and is presently providing treatments in oncology and hematology. The introduction of Kopozgo in India marks an extension of Bristol Myers Squibb’s therapeutic offerings into cardiology. This development builds on the company’s strong presence in oncology and hematology, representing an expansion of its portfolio. BMS aims to offer best-in-class global treatments to patients in India and is committed to bringing more medicines to more patients faster.
14, Oct 2025
Record-Low Inflation Opens Window for Growth Acceleration: PHDCCI
India, 14th oct 2025: CPI has seen a sharp decline in India’s headline inflation to 1.54% in September 2025, the lowest in over eight years according to the date released by Ministry of Statistics & Programme Implementation today.
“The record-low inflation offers a strong foundation for India’s next phase of growth. It is a moment of opportunity to revitalize private investment, stimulate consumption, and accelerate job creation,” said Mr. Rajeev Juneja, President, PHDCCI in a press statement issued here today.
Food inflation (Provisional) regist
He added, “The moderation in food and fuel prices has provided much-needed relief to households and improved purchasing power. Going forward, we urge the government to leverage this price stability to enhance credit availability, ease of doing business, and export competitiveness, especially for MSMEs and labour-intensive sectors.”
This phase of low inflation should be complemented by accelerated implementation of infrastructure and logistics projects to lower input costs, further support for agriculture supply chains to prevent food price spikes, and continued focus on technology-driven productivity gains in manufacturing and services, he added.
We anticipate that India’s inflation will remain within a comfortable range over the next two quarters, supported by adequate food supplies, moderate energy costs, and prudent monetary management by the Reserve Bank of India said Dr. Ranjeet Mehta, CEO & Secretary General, PHDCCI.
14, Oct 2025
Indian Cancer Society Unveils Breast Cancer Awareness Film
Indian Cancer Society Launches Breast Cancer Awareness Film Inspiring Women to Break the Stigma and Stay Two Steps Ahead of breast cancer
Mumbai, 14th October 2025: The Indian Cancer Society (ICS), dedicated to raising awareness and supporting those affected by cancer, is proud to announce the launch of its new film on breast cancer awareness, aimed at breaking the stigma, encouraging early detection, and inspiring communities through powerful storytelling. Through an impactful message, the film seeks to promote proactive health-seeking behaviour and spread hope among patients, survivors, and families. This initiative is part of our ongoing commitment to empower individuals with knowledge and encourage a united fight against breast cancer.
According to GLOBOCAN 2022, breast cancer is the most common cancer among women in India, accounting for approximately 26.6% of all female cancers. In 2022, an estimated 192,020 new cases of breast cancer were reported among women in the country, and the number of new cases is projected to continue increasing in the coming years.
Late diagnosis continues to be a key challenge, as many women are diagnosed at advanced stages, leading to reduced survival rates. Delayed diagnosis is tied to a lack of awareness, socio-economic factors, stigma, cultural barriers and limited access to diagnostic and treatment facilities. To address these challenges, the Indian Cancer Society has come up with a new film on breast cancer awareness and plans to roll out a campaign, timed with Breast Cancer Awareness Month.
The film uses the simple, everyday act of “touch” to convey the power of self-examination in early detection of breast cancer. It shows a woman who uses her touch daily to care for others and make everyday judgments checking her child’s temperature, checking fruit ripeness, food doneness, or fabric quality etc. The same caring touch that ensures others’ well-being can also protect her own life.
This short film highlights the importance of Self-Breast Examination (SBE), which is recommended for all, especially the premenopausal women between the 5th and 10th day of their menstrual cycle, and on one fixed day each month for postmenopausal women. The complete details of SBE and steps involved are captured in our website To know more, please visit, Indian Cancer Society – Breast Cancer
To maximize reach and impact, the film will be released in five languages (Hindi, Marathi, Telugu, Bengali and Kannada), enabling wider visibility and ensuring that people from diverse regions can connect with its message of awareness and hope. The film will be aired on Digital platforms like YouTube, Instagram, Facebook, LinkedIn, and screened through collaborations with hospitals, corporate partners, and community groups. “Through this film, ICS wants to bring attention to the fact that awareness is the first step to prevention,” said Mrs. Usha Thorat, Hon. Secretary and Managing Trustee, ICS. “By sharing real stories, we hope to inspire women to prioritize their health and encourage families to be supportive.”
As part of the campaign, several screening camps will be organized across the month, ensuring that awareness is coupled with timely action. This initiative underscores ICS’s unwavering commitment to empowering individuals with knowledge and driving meaningful change in the fight against breast cancer.
14, Oct 2025
Himalayan Siddhaa Akshar Ji’s Taiwan Visit: Bridging Himalayan Science and Modern Innovation
Taipei, Taiwan — 14th Oct 2025 — The recent visit of Himalayan Siddha Akshar Ji, a globally renowned spiritual leader and founder of Akshar Yoga Kendraa, to Taiwan marked a momentous convergence of ancient Himalayan Science of Consciousness with the technological prowess of Northeast Asia.
In a historic conversation between innovation and tradition, Grand Master Akshar ji presented a visionary integration of metaphysical knowledge and contemporary science, encouraging the audience to embrace conscious evolution in the digital age.
Rediscovering the Himalayas Within
Speaking to seekers, professionals, and innovators in Taiwan, Himalayan Siddhaa Akshar Ji shed light on the deeper nature of Yoga — not just a physical practice, but a path towards higher consciousness.
“Globally, humans practice yoga, but peace still evades us,” he declared.
“Change starts when we revisit ancient Himalayan processes and articulate them in language the contemporary mind can understand.”
He added that the Himalayas represent the pinnacle of awareness, a holy inner peak reached via quiet, equipoise, and harmony — despite the din of technological advancement.
Why Northeast Asia Resonates with Himalayan Wisdom
Nations like Taiwan, Japan, China, South Korea, and Hong Kong — the world over renowned for innovation and accuracy — possess an intrinsic cultural affinity with Himalayan philosophy. Their common desire for excellence, discipline, and finesse is reflective of the Siddha path of awareness and expertise.
“We shouldn’t be scared of technology or AI,” Grand Master Akshar ji clarified.
“They are not the issue — unconscious use is.”.
Spirituality and technology may evolve in concert when informed by consciousness.
This message struck a deep chord among Taiwan’s AI researchers, robotic engineers, and research scientists, most of whom understood that the inherent purpose of technology is not about dependence, but human evolution.
Bridging Metaphysics and Modern Science
In interactive classes and meditative sessions, Siddhaa Akshar Ji deciphered ancient yogic sciences — like Bhramari Pranayama — using the language of contemporary physics and neuro-energetics.
He uncovered how sound, geometry, and breathing comprise an exact energy architecture within the human system, correlating neural circuits and vibrational spaces to expanded states of consciousness.
Further elaborating, he equated yogic experiences with theories such as wormholes, time dilation, and fluidity of consciousness, leading participants to navigate shifted observation of time and space using controlled attention and energy techniques.
Translating Himalayan wisdom into the terms of quantum mechanics and consciousness science, Grand Master Akshar made spirituality a concrete, measurable reality from vague mysticism.
Evolving Beyond — From Human to Superhuman
The Taiwan sessions ended in a profound realization by participants:
“Spirituality is not about giving up the world — it is about upgrading yourself.”
Through the Himalayan Science of Consciousness, Grand Master Akshar reinforced the fact that enlightenment was not an accident but a methodical evolution possible through disciplined control of breath, mind, and energy.
When inner technology (Prana, Mind, Sound) harmonizes with outer technology (AI, Communication, Science), humanity moves toward a new era — one where peace and progress coexist.
A Living Transmission of Awareness
Himalayan Siddhaa Akshar ji’s visit to Taiwan served as a transmission of energy and consciousness, reminding audiences that the wisdom of the Himalayas is not ancient history, but a living, evolving science guiding modern civilization toward balance and awareness.
As his speech and presence echoed throughout Taiwan’s mountains and cities, a silence awakened — from geeks to truth seekers.
14, Oct 2025
Apollo Hospitals to Host ‘Global Voices One Vision’ International Health Dialogue 2026 in Hyderabad
Global Voices One Vision’ International Health Dialogue 2026 by Apollo Hospitals to be held in Hyderabad on January 30–31, 2026
Ahmedabad, 14 October, 2025: Apollo Hospitals will host the 2026 edition of International Health Dialogue (IHD), one of the world’s leading platforms advancing patient safety, healthcare innovation, and system transformation, on January 30–31, 2026, in Hyderabad, India. The theme for IHD 2026, ‘Global Voices. One Vision’, reflects a shared commitment to align ideas, innovations, and leadership toward a common goal – building resilient, patient-centric, and technology-enabled healthcare systems. The program this year will focus on three defining dimensions: leadership-driven safety models, human-centered design, digital transformation, and system-wide excellence in hospital operations, patient experience and clinical outcomes.
Dr. Sangita Reddy, Joint Managing Director, Apollo Hospitals Group said “Over the years, the International Health Dialogue has evolved into a dynamic global platform where clinicians, innovators, policymakers, and evangelists converge to shape the next era of healthcare. The Hyderabad edition builds on this vision — bringing together the power of AI, data, and digital ecosystems with the timeless values of empathy and collaboration. At its heart, IHD represents a shared global commitment to make healthcare more predictive, sustainable, and inclusive, where every innovation serves humanity and every partnership drives progress toward a healthier planet.”
International Health Dialogue 2026 integrates four defining conferences and learning streams under a single umbrella:
- IPSC – International Patient Safety Conference discusses how proactive practices and healthcare systems can improve patient safety.
- HOPE – Healthcare Operations & Patient Experience Conference focuses on operational excellence by integrating efficiency, empathy, and innovation to enhance every touchpoint of the patient journey.
- THIT – Transforming Healthcare with IT Conference brings together healthcare and IT leaders from around the world to share insights, best practices, and the latest advancements in the industry.
- CLINOVATE – Clinical CME Series on Oncology, Cardiology, Women’s Health, Longevity and Laboratory Medicine will offer clinicians and researchers access to high-impact, practice-focused learning led by renowned experts from India and around the world.
The International Health Dialogue 2026 will see an extraordinary gathering of global health visionaries and changemakers. Leading this exchange of ideas will be Dr. Jonathan Perlin, President and CEO of The Joint Commission Enterprise; Dr. Carsten Engel, CEO of ISQua; and Dr. Dean Ho, Head of the Department of Biomedical Engineering at the National University of Singapore. Joining them will be Dr. Atul Mohan Kochhar, CEO of NABH; Dr. Neelam Dhingra, Vice President and Chief Patient Safety Officer at Joint Commission International; and Dr. Eyal Zimlichman, Chief Innovation, Transformation and AI Officer at Sheba Medical Center, and Founding Director of ARC, Israel, Christian Schuhmacher, Founder and Managing Director of Swiss Global Advisory, Dubai, and Eric Langshur, Co-Founder and Managing Partner of Abundant Venture Partners. Together, they will bring a wealth of global perspectives to reimagine the future of healthcare — powered by data, empathy, and shared purpose.
This year’s conference will feature Safe-A-Thon a collaborative, solution-building challenge designed to spark innovation in patient safety to tackle real-world safety problems with smart, scalable, and cost-effective solutions. The conference will also witnss the launch of THNX (Technology & Healthcare Network eXchange) – India’s first digital health startup community that will feature pitch days, funding opportunities, and investor interactions.
Over the years, the International Health Dialogue has created a vibrant exchange between public health leaders, technology innovators, clinicians, and patient advocates. The 2026 edition in Hyderabad will continue this legacy through plenary discussions, innovation showcases, technology demonstrations, and global networking forums, offering participants an immersive experience in thought leadership and practical innovation.
14, Oct 2025
How to Host a 2025-Era Diwali: Products to Simplify Your Celebration
India,14th oct 2025: As the festive lights shimmer and the air fills with the scent of sweets, it’s time to welcome the joy and togetherness that Diwali brings. This Diwali, go beyond the diyas and sweets, make your celebrations smarter, sustainable, and effortlessly elegant. Whether you are hosting a family dinner, a card night, or just decking up your home, here are four products that add a modern touch to your festive hosting.
- Voltas Beko 25L Convection Microwave Oven For Effortless Festive Feast
With its 10 auto-cook programs, digital display, and Active Defrost technology, this sleek microwave helps you whip up quick snacks and reheat festive delicacies perfectly. From crispy samosas to soft gulab jamuns everything’s ready in minutes, letting you focus on your guests, not the cooking.
- Polycab Vigaro Clear LED Gate Light For Lighting That Welcomes Prosperity
Your guests’ first impression starts at the door and nothing says “Diwali-ready” like a beautifully lit entrance. The Polycab Vigaro Clear LED Gate Light brings a warm white glow that instantly adds charm to balconies, gardens, or pathways. Elegant yet durable, it’s the perfect way to set a festive mood while keeping your home eco-friendly.
- Dyson Purifier Cool Gen1 For Fresh Air and Clear Celebrations
With festive lights come firecrackers and sometimes, unwanted pollution. The Dyson Purifier Cool Gen1 ensures your guests breathe easy this Diwali. It removes dust, smoke, and allergens while keeping your space cool and comfortable. A sleek blend of innovation and wellness, it’s the ultimate addition to a modern Indian home during the festive season.
- Philips Smart Wi-Fi LED Bulbs For Mood Lighting That Matches Every Moment
Transform your home into a light show of your own with Philips Smart Wi-Fi Bulbs. Control brightness, switch between colours, and set ambient tones all through your smartphone or voice commands. Whether it’s a bright, lively card night or a warm family dinner, your lights can match the vibe instantly.
This Diwali, blend tradition with technology from smart lighting to quick cooking and eco-conscious décor and host your most modern, meaningful celebration yet.
14, Oct 2025
PVL 2025: Bengaluru Torpedoes register fourth straight win of the season
14th October, 2025: Bengaluru Torpedoes defeated Chennai Blitz 17-15, 14-16, 17-15, 16-14 in the RR Kabel Prime Volleyball League powered by Scapia at the Gachibowli Indoor Stadium, Hyderabad on Monday, to continue their winning run in the tournament. Joel Benjamin was named the Player of the Match.
Chennai started the game at a lightning-fast pace with captain Jerome Vinith and Luiz Felipe Perotto leading the charge. Tarun Gowda synced well with setter Sameer to provide more depth to the Blitz’s attacks.
Bengaluru relied on Joel Benjamin and Sethu to counter-attack. Mujeeb, Jishnu, and Nitin Minhas helped the Torpedoes in dominating the middle zone.
Once the Torpedoes’ defence began working in tandem, Chennai started finding it difficult to stitch their attacks. Libero Midhunkumar defended well for the Torpedoes, while skipper Mathew West ensured to find the right target for his passes.
Jerome and Perotto continued Chennai’s fightback. A couple of unforced errors from the Torpedoes opened up the door for the Blitz to make a comeback in the game. Blocker Aditya Rana’s presence on court put belief back in Chennai’s court.
Penrose made it count at a crucial juncture to tilt the game back in the Torpedoes’ corner. Two smart reviews from Coach David Lee proved fruitful, ensuring Bengaluru stayed in the lead. Penrose grew in confidence as the night progressed and brought the goods when Bengaluru needed the most, and the Torpedoes won the game 3-1.
